Treatment With Recombinant Human Tumor Necrosis Factor-Alpha Protects Rats Against the Lethality, Hypotension, and Hypothermia of Gram-Negative Sepsis.

Journal of Clinical Investigation - United States
doi 10.1172/jci115298
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis

Therapeutics and Clinical Risk Management
2008English

Tumor Necrosis Factor Alpha Protects Retinal Ganglion Cells Against Excitotoxicity via Reduction of Oxidative Stress in the Mice

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

TFPI-2 Protects Against Gram-Negative Bacterial Infection

Frontiers in Immunology
AllergyImmunology
2018English

Infection of Human Fallopian Tube Epithelial Cells With Neisseria Gonorrhoeae Protects Cells From Tumor Necrosis Factor Alpha-Induced Apoptosis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2006English

Chronic Recurrent Multifocal Osteomyelitis: Treatment With a Tumor Necrosis Factor-Alpha Inhibitor

Turkish Journal of Rheumatology
2013English

Recombinant Tumor Necrosis Factor Alpha and Interleukin 1 Alpha Increase Expression of C-Abl Protooncogene mRNA in Cultured Human Marrow Stromal Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Matrix Metalloproteinase-Mediation of Tumor Targeting Human Recombinant Tumor Necrosis Factor-Α Fusion Protein

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

The Synergistic Effect of Human Recombinant Tumor Necrosis Factor (TNF) in Combination With Hyperthermia and Its Mechanism

Thermal Medicine(Japanese Journal of Hyperthermic Oncology)
1988English

Appearance of ANCA – Associated Vasculitis Under Tumor Necrosis Factor-Alpha Inhibitors Treatment

American Journal of Case Reports
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy